Rayyan Zafar & Jaime Brambila Medi cannabis & psychedelics as adjunctive treatment in breast cancer

Rayyan Zafar and Jaime Brambila discuss the potential of using medical cannabis and psilocybin as adjunctive treatments for patients with advanced stage-4 breast cancer. Their work highlights the potential direct anti-cancer effects of these substances when integrated with standard therapies like chemotherapy. They present a patient case study that demonstrates how these treatments potentially contributed to the reduction of cancer symptoms and improved overall quality of life. The presenters emphasize the current lack of clinical trials and the need for further research to move toward prescription access. Furthermore, the discussion highlights the complex intracellular signaling pathways involved in how cannabinoids and psilocybin may interact with tumor cells to inhibit growth and promote programmed cell death. They address the importance of using whole-plant extracts rather than isolated compounds to achieve more effective results and the necessity for a systems-pharmacology approach in cancer treatment. The talk underscores a shift in how medical researchers and practitioners think about incorporating plant-based medicines into standard care.